Table 1 Characteristics of Chinese obese participants with various levels of Lp(a)
From: Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients
Variables | All Study Subjects | P value | ||
|---|---|---|---|---|
Lower Lp(a) | Moderate Lp(a) | Higher Lp(a) | ||
(n = 137) | (n = 137) | (n = 136) | ||
Age (years) | 31 ± 0.79 | 32 ± 0.76 | 33 ± 0.86 | 0.271 |
Gender-M/F | 59 / 78 | 62 / 75 | 51 / 85 | 0.408 |
BMI (kg/m2) | 38.82 ± 0.55 | 40.20 ± 0.67 | 38.35 ± 0.65 | 0.097 |
TC (mmol/L) | 4.73 ± 0.09 | 4.78 ± 0.08 | 4.97 ± 0.09 * | 0.016* |
TG (mmol/L) | 1.77 (1.20–2.68) | 1.67 (1.22–2.50) | 1.59 (1.32–2.00) | 0.114 |
HDL-C (mmol/L) | 1.03 ± 0.02 | 1.01 ± 0.02 | 1.07 ± 0.02 | 0.076 |
LDL-C (mmol/L) | 3.00 ± 0.07 | 3.06 ± 0.06 | 3.24 ± 0.07 *# | < 0.001** |
FBG (mmol/L) | 5.71 (5.14–7.53) | 5.80 (5.39–7.13) | 5.75 (5.32–6.81) | 0.591 |
FINS (uIU/ml) | 25.36 (18.98–41.34) | 26.91 (17.89–40.39) | 24.13 (17.39–35.83) | 0.319 |
GH (ng/ml) | 0.03 (0.02–0.10) | 0.04 (0.02–0.12) | 0.05 (0.03–0.20) ** | 0.006* |
TES (nmol/L) | 3.24 (1.95–9.30) | 3.10 (1.78–8.36) | 2.21 (1.54–7.18) **# | 0.003* |
HFSH (mIU/ml) | 5.21 (3.71–6.94) | 5.10 (3.82–6.60) | 5.17 (2.99–6.96) | 0.885 |
LH (mIU/ml) | 5.02 (3.19–7.50) | 5.03 (3.36–7.07) | 5.05 (3.20–7.84) | 0.979 |
PRL (mIU/ml) | 253.49 (188.79–347.58) | 301.51 (190.80–400.54) | 257.92 (182.92–358.71) | 0.205 |
E2(pmol/L) | 208.18 (143.13–281.61) | 181.07 (133.48–292.58) | 205.49 (147.40–314.56) | 0.277 |
HOMA-IR | 7.12 (4.85–12.89) | 7.74 (4.83–12.01) | 6.84 (4.49–10.42) | 0.355 |